Sanofi AMLITELIMAB – COAST1, COAST2 and SHORE Northam Investigator Meeting

Question Title

* 1. Please choose which best describes your role in the meeting.

Sponsor

Principle Investigator/Sub Investigator

Study Coordinator / Site Staff

Vendor

Other (please specify)

If Other selected, please specify:

Question Title

* 2. Please choose which best describes the region you represent.

Americas (North and South Americas)

Asia Pacific

Europe

Middle East and Africa (MEA)

Question Title

* 3. Please provide the country where you currently reside.

Question Title

* 4. Please rate the following

	1 Strongly Disagree	2 Disagree	3 Neither Agree nor Disagree	4 Agree	5 Strongly Agree
The content was aligned with the description/objectives.	The content was aligned with the description/objectives. 1 Strongly Disagree	The content was aligned with the description/objectives. 2 Disagree	The content was aligned with the description/objectives. 3 Neither Agree nor Disagree	The content was aligned with the description/objectives. 4 Agree	The content was aligned with the description/objectives. 5 Strongly Agree
The format of the meeting was conducive to a high level of interaction.	The format of the meeting was conducive to a high level of interaction. 1 Strongly Disagree	The format of the meeting was conducive to a high level of interaction. 2 Disagree	The format of the meeting was conducive to a high level of interaction. 3 Neither Agree nor Disagree	The format of the meeting was conducive to a high level of interaction. 4 Agree	The format of the meeting was conducive to a high level of interaction. 5 Strongly Agree
The sessions provided a sufficient forum to address questions and provide input.	The sessions provided a sufficient forum to address questions and provide input. 1 Strongly Disagree	The sessions provided a sufficient forum to address questions and provide input. 2 Disagree	The sessions provided a sufficient forum to address questions and provide input. 3 Neither Agree nor Disagree	The sessions provided a sufficient forum to address questions and provide input. 4 Agree	The sessions provided a sufficient forum to address questions and provide input. 5 Strongly Agree
The content adequately prepared me to conduct the clinical trial	The content adequately prepared me to conduct the clinical trial 1 Strongly Disagree	The content adequately prepared me to conduct the clinical trial 2 Disagree	The content adequately prepared me to conduct the clinical trial 3 Neither Agree nor Disagree	The content adequately prepared me to conduct the clinical trial 4 Agree	The content adequately prepared me to conduct the clinical trial 5 Strongly Agree
I felt motivated at the end of the meeting.	I felt motivated at the end of the meeting. 1 Strongly Disagree	I felt motivated at the end of the meeting. 2 Disagree	I felt motivated at the end of the meeting. 3 Neither Agree nor Disagree	I felt motivated at the end of the meeting. 4 Agree	I felt motivated at the end of the meeting. 5 Strongly Agree
I understand the importance of this clinical trial to the Sponsor in the development of the product.	I understand the importance of this clinical trial to the Sponsor in the development of the product. 1 Strongly Disagree	I understand the importance of this clinical trial to the Sponsor in the development of the product. 2 Disagree	I understand the importance of this clinical trial to the Sponsor in the development of the product. 3 Neither Agree nor Disagree	I understand the importance of this clinical trial to the Sponsor in the development of the product. 4 Agree	I understand the importance of this clinical trial to the Sponsor in the development of the product. 5 Strongly Agree
The meeting was well organized.	The meeting was well organized. 1 Strongly Disagree	The meeting was well organized. 2 Disagree	The meeting was well organized. 3 Neither Agree nor Disagree	The meeting was well organized. 4 Agree	The meeting was well organized. 5 Strongly Agree

Question Title

* 5. In your opinion, what where the meeting's strengths and what areas could be improved?

[a] Strengths:

[b] Improvement areas:

	Exceeded Expectations	Met Expectations	Did Not Meet Expectations	Not Applicable
Online Registration	Online Registration Exceeded Expectations	Online Registration Met Expectations	Online Registration Did Not Meet Expectations	Online Registration Not Applicable
Travel Agent	Travel Agent Exceeded Expectations	Travel Agent Met Expectations	Travel Agent Did Not Meet Expectations	Travel Agent Not Applicable
Hotel	Hotel Exceeded Expectations	Hotel Met Expectations	Hotel Did Not Meet Expectations	Hotel Not Applicable
Ground Transportation	Ground Transportation Exceeded Expectations	Ground Transportation Met Expectations	Ground Transportation Did Not Meet Expectations	Ground Transportation Not Applicable
Onsite Staff Experience/Support	Onsite Staff Experience/Support Exceeded Expectations	Onsite Staff Experience/Support Met Expectations	Onsite Staff Experience/Support Did Not Meet Expectations	Onsite Staff Experience/Support Not Applicable

Sanofi AMLITELIMAB – COAST1, COAST2 and SHORE Northam Investigator Meeting_SAN70827

Question Title

* 1. Please choose which best describes your role in the meeting.

Question Title

* 2. Please choose which best describes the region you represent.

Question Title

* 3. Please provide the country where you currently reside.

Question Title

* 4. Please rate the following

Question Title

* 5. In your opinion, what where the meeting's strengths and what areas could be improved?

Question Title

* 6. What was the most important take-away message you received from this meeting?

Question Title

* 7. Important topics or information I needed covered but were not addressed during the meeting include:

Question Title

* 8. Please rate your experience with the MTA Services